High-tech Clinical Trial Subject Database Strengthens CenExel Site Network
February 22, 2022. GLOBENEWSWIRE, INC.
CenExel Clinical Research, Inc., (“CenExel”) announces the acquisition of CTSdatabase, a cutting edge and global duplicate subject detection service. CTSdatabase not only detects clinical trial subjects who are currently participating in other studies, it can offer the history of a subject’s past study participation and a personalized investigation of actionable matches.